Ingevity Corp (NGVT) — SEC Filings

Latest SEC filings for Ingevity Corp (NGVT), explained in plain English.

Sentiment Overview: 2 bullish, 1 bearish, 41 neutral, 1 mixed

Recent Filings (45)

• Ingevity Corp Files Form 4: Ownership Changes Reported — 4 · 2026-04-09T17:30:13-04:00 [neutral] Risk: low
  On April 9, 2026, Ingevity Corp filed a Form 4, reporting changes in beneficial ownership of securities. The filing details transactions related to the company'
• Ingevity Corp. Files 8-K: Material Agreement & Financial Obligation — 8-K · 2026-03-30T06:30:49-04:00 [neutral] Risk: medium
  On March 26, 2026, Ingevity Corp. entered into a material definitive agreement, as detailed in Item 1.01 of their 8-K filing. This agreement also created a dire
• Ingevity Corp Files Routine 8-K — 8-K · 2025-12-08T00:00:00.000Z [neutral] Risk: low
  On December 8, 2025, Ingevity Corporation filed an 8-K report detailing a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not co
• Ingevity Corp Files 8-K on Dec 1, 2025 — 8-K · 2025-12-01T00:00:00.000Z [neutral] Risk: low
  Ingevity Corporation filed an 8-K on December 1, 2025, reporting on matters including Regulation FD Disclosure and Financial Statements and Exhibits. The filing
• Ingevity Swings to Profit in Q3, Narrows YTD Loss Amid Divestiture — 10-Q · 2025-11-06T00:00:00.000Z [mixed] Risk: medium
  Ingevity Corp (NGVT) reported a net income of $43.5 million for the three months ended September 30, 2025, a significant improvement from a net loss of $107.2 m
• 8-K Filing — 8-K · 2025-11-05T00:00:00.000Z [neutral]
• Ingevity Corp Files 8-K: Director, Officer, and Compensation Updates — 8-K · 2025-10-23T00:00:00.000Z [neutral] Risk: low
  On October 23, 2025, Ingevity Corporation filed an 8-K report detailing changes in its board of directors and certain officers, along with updates to compensato
• Ingevity Corp Files 8-K: Material Agreement, Financials — 8-K · 2025-09-04T00:00:00.000Z [neutral] Risk: medium
  On September 3, 2025, Ingevity Corporation entered into a Material Definitive Agreement. The filing also includes Regulation FD Disclosures and Financial Statem
• Ingevity Q2 Sales Dip 10.2% Amid Weak Demand, Net Income Plunges 35.7% — 10-Q · 2025-08-05T00:00:00.000Z [bearish] Risk: high
  Ingevity Corp reported a net sales decrease of 10.2% to $390.5 million for the second quarter of 2025, down from $434.9 million in the prior year's second quart
• Ingevity Corp. Files 8-K on Financials — 8-K · 2025-08-04T00:00:00.000Z [neutral] Risk: low
  On August 4, 2025, Ingevity Corp. filed an 8-K report detailing results of operations and financial condition. The filing includes financial statements and exhi
• Ingevity Corp Files 8-K: Director Changes & Officer Compensation Updates — 8-K · 2025-07-01T00:00:00.000Z [neutral] Risk: low
  On July 1, 2025, Ingevity Corporation filed an 8-K report detailing the departure of a director, the election of a new director, and updates to compensatory arr
• Ingevity Corp. Files Q1 2025 10-Q — 10-Q · 2025-05-06T00:00:00.000Z [neutral] Risk: low
  Ingevity Corp. reported its first quarter 2025 results for the period ending March 31, 2025. The company's filing details financial performance across its vario
• Ingevity Corp Files 8-K on Financials — 8-K · 2025-05-05T00:00:00.000Z [neutral] Risk: low
  On May 5, 2025, Ingevity Corp. filed an 8-K report detailing results of operations and financial condition, along with financial statements and exhibits. The fi
• Ingevity Corp Files 8-K on Director Changes and Compensation — 8-K · 2025-05-01T00:00:00.000Z [neutral] Risk: low
  On April 30, 2025, Ingevity Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also
• Ingevity Corp Enters Material Definitive Agreement — 8-K · 2025-03-31T00:00:00.000Z [neutral] Risk: medium
  On March 30, 2025, Ingevity Corporation entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this
• Ingevity Corp Files Proxy Materials — DEFA14A · 2025-03-20T00:00:00.000Z [neutral] Risk: low
  Ingevity Corporation filed a Definitive Additional Materials proxy statement on March 20, 2025. This filing is related to their annual meeting and likely concer
• Ingevity Corp Files DEFA14A Proxy Statement — DEFA14A · 2025-03-12T00:00:00.000Z [neutral] Risk: low
  On March 12, 2025, Ingevity Corporation (INGV) filed a DEFA14A, indicating they issued a press release. The filing mentions Ingevity naming M. Ingevity Corporat
• Ingevity Corp Files 8-K on Director/Officer Changes — 8-K · 2025-03-10T00:00:00.000Z [neutral] Risk: low
  On March 10, 2025, Ingevity Corporation filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing indi
• Ingevity Corp Files Proxy Statement — DEFA14A · 2025-02-25T00:00:00.000Z [neutral] Risk: low
  Ingevity Corporation filed a DEFA14A on February 25, 2025, related to its proxy statement. The filing is for the company itself, Ingevity Corp, and concerns sol
• Ingevity Corp Files 2024 10-K — 10-K · 2025-02-19T00:00:00.000Z [neutral] Risk: medium
  Ingevity Corp filed its 2024 10-K on February 19, 2025, reporting on its fiscal year ending December 31, 2024. The company, incorporated in Delaware, operates i
• Ingevity Corp Files 8-K on Financials — 8-K · 2025-02-18T00:00:00.000Z [neutral] Risk: low
  Ingevity Corporation filed an 8-K on February 18, 2025, reporting on its results of operations and financial condition. The filing includes financial statements
• Ingevity Corp Files 8-K for Operations Update — 8-K · 2025-01-16T00:00:00.000Z [neutral] Risk: low
  Ingevity Corporation filed an 8-K on January 16, 2025, to report on its results of operations and financial condition, as well as to provide a Regulation FD dis
• Ingevity Corp Reports Board Changes and Executive Compensation Updates — 8-K · 2024-12-16T00:00:00.000Z [neutral] Risk: low
  On December 16, 2024, Ingevity Corporation filed an 8-K report detailing changes in its board of directors and executive compensation. Specifically, the filing
• SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-11-04T00:00:00.000Z [neutral]
• Ingevity Corp. Files Q3 2024 10-Q Report — 10-Q · 2024-10-30T00:00:00.000Z [neutral] Risk: medium
  Ingevity Corp. reported its third-quarter results for the period ending September 30, 2024. The company's financial performance for the quarter and year-to-date
• Ingevity Corp Files 8-K on Financials — 8-K · 2024-10-29T00:00:00.000Z [neutral] Risk: low
  Ingevity Corporation filed an 8-K on October 29, 2024, reporting on its results of operations and financial condition. The filing includes financial statements
• Ingevity Corp Files 8-K with Bylaw Amendments — 8-K · 2024-10-25T00:00:00.000Z [neutral] Risk: low
  On October 22, 2024, Ingevity Corporation filed an 8-K report detailing amendments to its Articles of Incorporation and Bylaws. The filing also included financi
• Ingevity Corp: Board Changes and CFO Employment Agreement — 8-K · 2024-10-03T00:00:00.000Z [neutral] Risk: low
  Ingevity Corporation announced on October 2, 2024, a change in its Board of Directors with the resignation of Robert J. Smith and the appointment of Dr. Michael
• Ingevity Corp Files 10-Q for Q2 2024 — 10-Q · 2024-08-01T00:00:00.000Z [neutral] Risk: medium
  Ingevity Corp filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first half of the year,
• Ingevity Corp Files 8-K on Exit Costs — 8-K · 2024-07-31T00:00:00.000Z [neutral] Risk: medium
  On July 29, 2024, Ingevity Corporation (NGVT) filed an 8-K detailing costs associated with exit or disposal activities. The filing also included a Regulation FD
• Ingevity Corp Enters New Agreement, Terminates Another — 8-K · 2024-07-08T00:00:00.000Z [neutral] Risk: medium
  On July 1, 2024, Ingevity Corporation entered into a material definitive agreement and terminated another. The company also made a Regulation FD disclosure and
• Ingevity Corp Announces Executive and Board Changes — 8-K · 2024-07-01T00:00:00.000Z [neutral] Risk: medium
  Ingevity Corporation announced on June 26, 2024, changes in its executive team and board of directors. The filing details the departure of certain officers and
• Ingevity Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · 2024-05-02T00:00:00.000Z [neutral] Risk: medium
  Ingevity Corp (NGVT) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Ingevity Corp reported financial results for the first quarter of 2024, ending
• Ingevity Corp Files 8-K on Financials — 8-K · 2024-05-01T00:00:00.000Z [neutral] Risk: low
  Ingevity Corporation filed an 8-K on May 1, 2024, reporting on its financial condition and results of operations. The filing includes financial statements and e
• Ingevity Corp Files 8-K on Security Holder Votes — 8-K · 2024-04-23T00:00:00.000Z [neutral] Risk: low
  On April 23, 2024, Ingevity Corporation filed an 8-K report indicating that matters were submitted to a vote of security holders. The filing also includes finan
• Ingevity Corp Appoints New Directors, Updates CFO Compensation — 8-K · 2024-03-14T00:00:00.000Z [neutral] Risk: low
  On March 12, 2024, Ingevity Corporation (NGVT) announced changes to its Board of Directors and executive compensation. Specifically, the company elected two new
• Ingevity Corp. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · 2024-03-11T00:00:00.000Z [neutral] Risk: low
  Ingevity Corp (NGVT) filed a Proxy Statement (DEF 14A) with the SEC on March 11, 2024. Ingevity Corp. filed a Definitive Proxy Statement (DEF 14A) on March 11,
• Inclusive Capital Partners Amends Ingevity Stake Filing — SC 13D/A · 2024-02-28T00:00:00.000Z [neutral] Risk: low
  Inclusive Capital Partners, L.P. filed an Amendment No. 3 to their Schedule 13D on February 26, 2024, regarding their ownership in Ingevity Corporation. The fil
• Ingevity Corp Files 2023 Annual Report on Form 10-K — 10-K · 2024-02-22T00:00:00.000Z [neutral] Risk: medium
  Ingevity Corp (NGVT) filed a Annual Report (10-K) with the SEC on February 22, 2024. Ingevity Corp filed its 2023 Form 10-K on February 22, 2024. The filing cov
• Ingevity Corp Files 8-K on Financial Condition and Operations — 8-K · 2024-02-21T00:00:00.000Z [neutral] Risk: low
  Ingevity Corp filed an 8-K on February 21, 2024, reporting on its results of operations and financial condition. The filing indicates that the company, incorpor
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• Wellington Management Takes 5% Passive Stake in Ingevity Corp — SC 13G · 2024-02-08T00:00:00.000Z [bullish] Risk: low
  Wellington Management Group LLP, a Massachusetts-based investment adviser, reported on February 8, 2024, that as of December 29, 2023, it beneficially owns 5.0%
• Victory Capital Discloses 1.84M Share Stake in Ingevity Corp. — SC 13G · 2024-02-07T00:00:00.000Z [bullish]
  Victory Capital Management Inc., a New York-based investment firm, reported on February 7, 2024, that it beneficially owns 1,839,610 shares of Ingevity Corp. co
• BlackRock Amends Ingevity Stake, Maintains Significant Holding — SC 13G/A · 2024-01-22T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, disclosing its ownership of Ingevity Corp. common stock as of December 31, 2023. This filing, an a